本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Autolus Therapeutics PLC

1.43
+0.08005.93%
盘后1.490.0600+4.20%18:20 EDT
成交量:116.66万
成交额:166.57万
市值:3.81亿
市盈率:-1.65
高:1.49
开:1.34
低:1.33
收:1.35
数据加载中...
2020/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/30

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/22

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/03

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/24

超过5%披露

General statement of acquisition of beneficial ownership
2020/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/20

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/07/22

SEC问询函

[Cover]Correspondence